Geometry.Net - Health_Conditions: Systemic Lupus Erythematosus


Home - Health_Conditions - Systemic Lupus Erythematosus

e99.com Bookstore

Images

Newsgroups

81-100 of 113 Back | 1 | 2 | 3 | 4 | 5 | 6 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Systemic Lupus Erythematosus: more books (101)

Adding prasterone appears beneficial in lupus. (Disease Activity, Bone Density).(systemic lupus erythematosus ): An article from: Family Practice News by Nancy Walsh, 2003-05-01
Intestinal pseudo-obstruction as a presenting manifestation of systemic lupus erythematosus: case report and review of the literature.(Case Report): An article from: Southern Medical Journal by Hien, Nguyen, Niharika Khanna, 2004-02-01
Myelitis mistaken for bladder infection in SLE.(systemic lupus erythematosus)(RHEUMATOLOGY): An article from: Internal Medicine News by M. Alexander Otto, 2010-08-01
Systemic Lupus Erythematosus: An entry from Gale's <i>Gale Encyclopedia of Medicine, 3rd ed.</i> by Rosalyn, MD Carson-DeWitt, 2006
Eosinophilic enteritis with systemic lupus erythematosus.(Case Report): An article from: Southern Medical Journal by Prashanth R. Sunkureddi, Nguyen Luu, et all 2005-10-01
SYSTEMIC LUPUS ERYTHEMATOSUS by DANIEL L LARSON, 1961-01-01
Systemic lupus erythematosus: An entry from Thomson Gale's <i>Gale Encyclopedia of Alternative Medicine</i> by Belinda Rowland, 2001
Vitamin D repletion in SLE requires 2,000 IU.(Systemic lupus erythematosus)(RHEUMATOLOGY): An article from: Internal Medicine News by M. Alexander Otto, 2010-08-01
Systemic Lupus Erythematosus (Bailliere's Clinical Rheumatology)
Lupus Erythematosus :A Review of the current Status of Discoid and Systemic Lupus Erythematosus and Their Variants by Edmund L. Dubois, 1966
Managing organ-threatening systemic lupus erythematosus.(Best practice): An article from: MedSurg Nursing by Richard L., Jr. Pullen, Jan D. Cannon, et all 2003-12-01
Lupus Erythematosus: a Review of the Current Status of Discoid and Systemic Lupus Erythematosus and Their Variants by edmund dubois, 1974-01-01
Stem cell transplantation may improve refractory SLE.(News)(systemic lupus erythematosus): An article from: Internal Medicine News by Mitchel L. Zoler, 2005-04-15
Stem cell transplant therapy improves refractory SLE.(Clinical Rounds)(systemic lupus erythematosus): An article from: Skin & Allergy News by Mitchel L. Zoler, 2005-05-01

lists with details

Pathology Of Systemic Lupus Erythematosus
systemic lupus erythematosus (SLE) is a chronic disease with many manifestations.SLE is an autoimmune disease in which the body s own immune system is
http://www.mold-survivor.com/lupus.htm

Extractions: Systemic lupus erythematosus (SLE) is a chronic disease with many manifestations. SLE is an autoimmune disease in which the body's own immune system is directed against the body's own tissues. The etiology of SLE is not known. It can occur at all ages, but is more common in young women. The production of autoantibodies leads to immune complex formation. The immune complex deposition in many tissues leads to the manifestations of the disease. Immune complexes can be deposited in glomeruli, skin, lungs, synovium, mesothelium, and other places. Many SLE patients develop renal complications. The presence of autoantibodies can usually be determined by the antinuclear antibody (ANA) test performed on patient serum from blood. The titer, or strength, of the ANA gives a rough indication of the severity of the disease. Not all positive ANA tests indicate autoimmune disease, particularly when the titer is low. After a positive screening ANA test, more specific tests for SLE include detection of auto-antibodies to double stranded DNA and to Smith antigen. Skin rashes are common with SLE. The most characteristic rash is seen across the malar region of the face, the so-called "butterfly rash" that is accentuated by sun exposure. SLE must be distinguished from discoid lupus erythematosus (DLE) which affects the skin (but only in sun exposed regions) and is unlikely to be associated with systemic illness, such as renal disease. A biopsy of sun exposed skin that is not involved with a rash will demonstrate immune complex deposition with SLE, but not with DLE.
Systemic Lupus Erythematosus
systemic lupus erythematosus Adler, Jonathan. systemic lupus erythematosus ,eMedicine Journal, January 26 2001, Volume 2, Number 1
http://ist-socrates.berkeley.edu/~jmp/Lupus.html

Extractions: Cotran RS, Kumar V, Collins T. Pathologic Basis of Disease, 6th Edition. W.B. Saunders Co. pp. 188 - 195, 216 - 225 Adler, Jonathan. "Systemic Lupus Erythematosus", eMedicine Journal, January 26 2001, Volume 2, Number 1 Nowicki, Stella "Antiphospholipid Antibody Syndrome and Pregnancy", eMedicine Journal, September 28 2001, Volume 2, Number 9 Click here for the Peer Review page
BBC - Health - Conditions - Systemic Lupus Erythematosus
A guide to SLE, facts about the condition and where to go for support.
http://www.bbc.co.uk/health/conditions/sle1.shtml

Extractions: Send it to a friend! Dr Rob Hicks The autoimmune disease lupus is thought to affect up to 30,000 people in the UK, mostly women. Discover the common symptoms and treatments that can relieve them. What is it? What are the symptoms? How many people are affected? Prevention ... Treatment Systemic lupus erythematosus (SLE), often simply called lupus, is a chronic inflammatory disease that affects the blood vessels and connective tissues of the skin. It's an autoimmune disease where the body turns upon itself, causing the tissues to become inflamed and swollen. SLE is not contagious. The precise cause is unknown, although it may be triggered by hormones, infections, sunlight or stress. There are many possible symptoms. These may be mild or severe, with flare-ups occurring intermittently. SLE often begins with a skin rash over the nose and cheeks that is shaped like a butterfly and made worse by exposure to the sun. This may be accompanied by tiredness and pains in the joints. Thrombophlebitis, hair loss, painless mouth ulcers, headaches, anaemia, fits, high blood pressure, pleurisy, pericarditis and kidney disease may all occur.
Systemic Lupus Erythematosus
systemic lupus erythematosus (SLE). SLE is an immunemediated disease in whichthe immune system attacks the body s own organs. What causes this to happen
http://www.mesavet.com/library/sle.htm

Extractions: Mesa Veterinary Hospital is pleased to announce the arrival of Associate Veterinarian Dr. Michelle Moeller . Dr. Moeller comes to Mesa after completing a year-long internship at Animal Referral and Emergency Center of Arizona, where she focused on small animal medicine and surgery. WE HAVE A WINNER! The winner of our Senior Pet Challenge contest is Lesilie Peterson of Chandler, Arizona. Lesilie owns a senior dog and cats. She'll receive 100 pounds of Hill's Science Diet Dog Food. The winner was selected from the correct entries received. Congratulations Lesilie! SLE is an immune-mediated disease in which the immune system attacks the body's own organs. What causes this to happen is unknown, but certain breeds are thought to be affected more often. These include Shetland sheepdogs (Shelties), collies, Afghan hounds, and German shepherds. Symptoms can begin showing slowly, or very suddenly. Commonly, animals are brought in to the vet for lameness which is being caused by arthritis or muscle inflammation, but they may also be brought in for anorexia, weakness, fever, seizures, or swollen lymph nodes.
About - Lupus Erythematosus.
systemic lupus erythematosus, also called lupus or SLE for short, belongs to thefamily of rheumatic diseases. Rheumatic diseases affect joints,
http://www.orthop.washington.edu/uw/tabID__3376/ItemID__38/mid__10313/Articles/D

Extractions: Home Site Map Contact Us Links ... All Articles Lupus Erythematosus. University of Washington, Seattle Last updated Thursday, December 23, 2004 Basics of lupus erythematosus Systemic lupus erythematosus, also called lupus or SLE for short, belongs to the family of rheumatic diseases. Rheumatic diseases affect joints , muscles and other parts of the body, and often involve abnormalities of the immune system. Lupus can affect not only joints and muscles but also skin, kidneys, nervous system, lungs, heart and the blood-forming organs. Lupus is an autoimmune disease in which the tissues of the body are attacked by the overly active immune system and is treated by suppressing the immune system. There are two common forms of lupus: discoid and systemic. Discoid lupus is a disease of the skin which is often chronic and leads to scarring. It may be limited to the skin and not be associated with disease in any other body systems. In other cases, discoid lupus may be one of the features of the systemic form of lupus. This information focuses on the systemic form of the disease.
Entrez PubMed
systemic lupus erythematosuslike syndrome in monkeys fed alfalfa sprouts roleof a nonprotein amino acid. Malinow MR, Bardana EJ Jr, Pirofsky B, Craig S,
http://www.nutritionandmetabolism.com/pubmed/7071589

Extractions: My NCBI [Sign In] [Register] All Databases ... Books Search PubMed Protein Nucleotide Structure Genome Books CancerChromosomes Conserved Domains 3D Domains Gene Genome Project GENSAT GEO Profiles GEO DataSets HomoloGene Journals MeSH NCBI Web Site NLM Catalog OMIA OMIM PMC PopSet Probe PubChem BioAssay PubChem Compound PubChem Substance SNP Taxonomy UniGene UniSTS for Limits Preview/Index History Clipboard Details About Entrez PubMed Central Display Summary Brief Abstract Citation MEDLINE XML UI List LinkOut ASN.1 Related Articles Cited Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Gene (GeneRIF) Links Genome Links Project Links GENSAT Links GEO Profile Links HomoloGene Links Nucleotide Links OMIA Links OMIM Links BioAssay Links Compound Links Compound via MeSH Substance Links Substance via MeSH PMC Links Cited in PMC PopSet Links Probe Links Protein Links SNP Links Structure Links UniGene Links UniSTS Links Show Sort by Author Journal Pub Date Send to Text File Clipboard E-mail Order All: 1 Review: Science.
DermAtlas: Online Dermatology Image Library Dermatology Image,lupus Erythematosu
Comments, This 42year-old woman with systemic lupus erythematosus developeddigital DermAtlas VERMILLION BORDER - lupus erythematosus, systemic
http://dermatlas.med.jhmi.edu/derm/result.cfm?Diagnosis=-349425327
Systemic Lupus Erythematosus (SLE)
What is systemic lupus erythematosus ? Introduction systemic lupus erythematosus (SLE)is a chronic disease with many manifestations.
http://medindia.net/patients/patientinfo/sle.asp

Extractions: SYSTEMIC LUPUS ERYTHEMATOSUS Page 1 Disease info Related Topics Medical Acronyms Amazing Body Facts Phobias Medical Syndromes ... Teeth Chart Interactives (Flash) Brain Depression Eye Donation Brain Death Angioplasty ... Which doctor should I consult ? What is Systemic Lupus Erythematosus ? Introduction Systemic lupus Erythematosus (SLE) is a chronic disease with many manifestations. SLE is an autoimmune disease in which the body's own immune system is directed against the body's own tissues ( the body harms its own healthy cells and tissues ) leading to inflammation of various body tissues. It can occur at all ages, but is more common in young women. In addition, lupus can run in families, but the risk that a child or a brother or sister of a patient will also have lupus is still quite low. Lupus is a complex disease, the cause of which is unknown. In addition, some autoantibodies join with substances from the body's own cells or tissues to form molecules called immune complexes. A buildup of these immune complexes in the body also contributes to inflammation and tissue injury in persons with lupus. Researchers do not yet understand all the factors that cause inflammation and tissue damage in lupus.
Systemic Lupus Erythematosus (SLE).
Patients with or suspected to have systemic lupus erythematosus (SLE) systemic lupus erythematosus (SLE) is a syndrome characterized by clinical
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=5675&nbr=3813
Systemic Lupus Erythematosus (SLE).
systemic lupus erythematosus (SLE) is a syndrome characterized by clinicaldiversity, changes in the disease activity over time, and by aberrant
http://www.guideline.gov/summary/summary.aspx?doc_id=5675
Adult Health Advisor 2004.2: Systemic Lupus Erythematosus
systemic lupus erythematosus (SLE) is an autoimmune disease. This means that yourbody s defenses against infection are attacking your own tissue.
http://www.med.umich.edu/1libr/aha/um_lupus_crs.htm

Extractions: This information is approved and/or reviewed by U-M Health System providers but it is not a tool for self-diagnosis or a substitute for medical treatment. You should speak to your physician or make an appointment to be seen if you have questions or concerns about this information or your medical condition. Index Spanish version Systemic lupus erythematosus (SLE) is an autoimmune disease. This means that your body's defenses against infection are attacking your own tissue. This causes inflammation. Areas of the skin or joints become painful, red, and swollen. Other parts of the body can also become inflamed and injured, including the muscles, kidneys, nervous system, blood, lungs, and heart. SLE, also called lupus, is a serious, chronic disease, which means it rarely goes away completely. Some people have severe, even fatal, cases of lupus, but for most people symptoms can be controlled. Lupus affects mainly young women. In the US it is more common among African American, Hispanic, Asian, and Native American women than Caucasians.
Lupus Erythematosus, Systemic
This document on systemic lupus erythematosus is provided by H. Michael Belmont This booklet describes what systemic lupus erythematosus is and covers
http://omni.ac.uk/browse/mesh/D008180.html

Extractions: low graphics Lupus Erythematosus, Systemic Lupus Erythematosus, Systemic / pathology broader: Autoimmune Diseases other: Addison Disease Antiphospholipid Syndrome Arthritis, Rheumatoid Dermatitis Herpetiformis ... Thyroiditis, Autoimmune Lupus Clinical Overview This document on systemic lupus erythematosus is provided by H. Michael Belmont of The Lupus Clinic, Hospital for Joint Diseases, New York University Medical Center. Topics covered include symptoms, systemic effects, diagnostic procedures and pitfalls and errors. Lupus Erythematosus, Systemic Handout on health : systemic lupus erythematosus This booklet on systemic lupus erythematosus is produced by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This booklet describes what systemic lupus erythematosus is and covers clinical signs and symptoms, diagnosis, available treatments, health care, pregnancy, and quality of life for people with lupus. Aimed at people who have systemic lupus erythematosus, and their families, this booklet was revised in February 2000. Patient Education Handout [Publication Type] Lupus Erythematosus, Systemic
Systemic Lupus Erythematosus - Swedish Medical Center, Seattle, Washington
systemic lupus erythematosus Swedish Medical Center, Seattle, Washington.
http://www.swedish.org/14582.cfm

Extractions: PDF Version Search Send-to-Friend Health Library Home ... Conditions InBrief by Rick Alan Definition Causes Risk Factors ... Prevention Systemic lupus erythematosus (or lupus) is an autoimmune disease that causes inflammation of joints, tendons, skin and other connective tissues and organs. It causes the immune system to produce antibodies that attack the body's healthy cells and tissues. The cause of lupus is unknown. Researchers believe it is caused by a combination of: Viral or other type of infection Antibiotics (especially those containing penicillin or sulfa) A risk factor is something that increases your chance of getting a disease or condition. Risk factors for lupus include: The symptoms of lupus vary from mild to extremely severe and debilitating. In some patients, only part of the body (for example, the skin) is affected. In others, many parts of the body are affected. Though symptoms of lupus can be chronic, they usually flare up and subside intermittently. Common symptoms include: Butterfly Rash on the Face www.nucleusinc.com
Systemic Lupus Erythematosus &
systemic lupus erythematosus (SLE) is a complex autoimmune disease characterizedby a loss of immunologic tolerance to a multitude of selfantigens.
http://www.broad.mit.edu/mpg/idrg/projects/sle.html

Extractions: genome center home programs inflammatory disease research group systemic lupus erythematosus The primary goal of this project is to identify the genes which predispose humans to developing Systemic Lupus Erythematosus (SLE). Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by a loss of immunologic tolerance to a multitude of self-antigens. It involves many organs and results in autoantibody production and tissue injury. Also, it mainly affects women of child-bearing age. Epidemiological data suggest an important role for genes in the etiology of lupus, and previous genetic studies have implicated the HLA locus, complement genes, and low-affinity IgG (Fcgamma) receptors in SLE pathogenesis. Relevant OMIM links: Last modified: Thu May 22 16:56:39 EDT 2003 Webmaster WICGR Home WI Home
HSS - Conditions & Treatments : Systemic Lupus Erythematosus (SLE)
Conditions Treatments systemic lupus erythematosus (SLE)
http://www.hss.edu/Conditions/Systemic-Lupus-Erythematosus-(SLE)

Extractions: Clinical Trials Fc Receptor Function in Normals and Systemic Lupus Erythematosus (SLE) document.write(textIcon('Conditions/Systemic-Lupus-Erythematosus-(SLE)/Clinical-Trial-93029')); document.write(audioIcon('Conditions/Systemic-Lupus-Erythematosus-(SLE)/Clinical-Trial-93029','0')); document.write(videoIcon('Conditions/Systemic-Lupus-Erythematosus-(SLE)/Clinical-Trial-93029','0')); PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE) document.write(textIcon('Conditions/Systemic-Lupus-Erythematosus-(SLE)/Clinical-Trial-22122')); document.write(audioIcon('Conditions/Systemic-Lupus-Erythematosus-(SLE)/Clinical-Trial-22122','0')); document.write(videoIcon('Conditions/Systemic-Lupus-Erythematosus-(SLE)/Clinical-Trial-22122','0'));
Disease Category Listing (144): Systemic Lupus Erythematosus
CenterWatch Listing of Clinical Research Trials for systemic lupus erythematosus.
http://www.centerwatch.com/patient/studies/cat144.html

Extractions: HSC# 9955, A randomized, double-blind, placebo-controlled, multicenter, Phase II/III study to evaluate the safety and efficacy of a B-cell depleting therapy in the treatment of patients with active moderate to severe systematic lupus erythematosus. Maryland Chevy Chase; The Center for Rheumatology and Bone Research - Chevy Chase, MD
Systemic Lupus Erythematosus Links, Articles And Topics At Suite101.com
Links, topics and articles at Suite101 related to systemic lupus erythematosus.
http://www.suite101.com/subjectheadings/contents.cfm/1027

Extractions: Member Central Join Our Community! Login SuiteMail What's New ... Become a Feature Writer Fun Suite Full Listing Contests Scribbles SuiteCards Free Newsletters Subscribe Here! Member Update Discussion Rooms The Forum The Lounge SuiteChat The Writers' Suite Community Stores The Co-op Store Biz Center Best of Suite eBooks Book Circle Community Channels Arts and Crafts Business and Economics Computers and Technology Education ... Youth Corner New Topics California Wine Macintosh Musings Papal History My Midlife Mania ... More... New Articles You Are What You Eat Science in the Fifth Grade Review: Book of Enchantments by Patricia Wrede The Watchmans Job Description ... More... New Discussions Fibro Friends' Support Group Cont'. Shall We Fiddle While Social Security Burns? The Bear Cafe - A Gathering Place for Bears - Others Welcome My new dogs breed? ... More... Suite Events Memories of Grandparents Post-Soviet Nations Fall Food Festival Suite University Visit the University About Suite University Suite University News Course Listing ... Student Testimonials New Free Courses Introduction to Hinduism The Last Charge: Culloden and the 'Forty-five Writing: A How-To for Kids Dreams and the Subconscious Mind ... More...
EMJA: Godfrey & Ryan, Systemic Lupus Erythematosus: Current Management
systemic lupus erythematosus is an autoimmune disease that may affect many organs, Currently, minor manifestations of systemic lupus erythematosus
http://www.mja.com.au/public/issues/175_03_060801/godfrey/godfrey.html

Extractions: Systemic lupus erythematosus is an autoimmune disease that may affect many organs, especially the skin, musculoskeletal, vascular and renal systems. It occurs predominantly in women of childbearing age, but also affects people in their sixth decade or older. In these patients, female predominance is less marked and renal disease less common. The natural history of the disease has changed over the past 20-30 years; survival rates have increased from 50% at five years in the 1950s to 80%-90% at 10 years in the 1990s. The explanations for this improvement include earlier diagnosis, recognition of milder disease, advances in medical therapy, and better supportive care, including renal replacement therapy. Despite these advances, the standardised mortality ratio for lupus remains at 3. Morbidity and mortality rates are bimodal, with early events related to disease activity or infection and later events often due to premature vascular disease such as stroke and myocardial ischaemia. Currently, minor manifestations of systemic lupus erythematosus (cutaneous, musculoskeletal, fatigue) are managed with non-steroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs (particularly hydroxychloroquine) and low-dose corticosteroids. The selective COX-2 inhibitors, celecoxib (a sulfonamide) and rofecoxib, are now available in Australia. With their lower gastrointestinal toxicity, they represent a significant advance. Patients with lupus, however, have a high prevalence of sulfonamide allergy (20% in some studies) and 30%-50% have antiphospholipid antibodies, which are associated with arteriovenous thrombosis and miscarriages (the antiphospholipid syndrome). Case reports of thrombotic events in patients with antiphospholipid antibodies taking COX-2 inhibitors necessitate judicious use of these drugs until further data are available.
Second EULAR Course On Systemic Lupus Erythematosus â British Society For R
Related. Local resources. Second EULAR Course on systemic lupus erythematosusEvents Second EULAR Course on systemic lupus erythematosus Courses
http://www.rheumatology.org.uk/education/event/eularcoursesle
European Lupus Erythematosus Federation
Lupus in internet Further informations about systemic lupus erythematosus andrelated topics in internet. SLE systemic lupus erythematosus
http://www.elef.rheumanet.org/

Extractions: Please send questions or comments to elef@rheumanet.org Converted to HTML by Team-RheumaNet So few have heard of it, yet worldwide it's seen as more common than leukaemia muscular dystrophy and multiple sclerosis. 90% of the patients who suffer from Lupus are female of childbearing age. Even young children can be affected by lupus. Lupus is a condition whereby the body's defence mechanism goes into overdrive and starts to attack itself. The symptoms are many and varied, and the illness often seems to mimic other diseases. This gives rise to difficulty in diagnosis and the condition can be overlooked, sometimes for years, unless the General Practioner or consultant is alert to the possibility of lupus. LUPUS IS NOT CONTAGIOUS Lupus can be triggered - at puberty - during the menopause - after childbirth - after viral infection - through sunlight - as a result of trauma - after a prolonged course of medication THE SYMPTOMS These may include - extreme fatigue - joint and muscle pain - eye problems - depression

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

81-100 of 113 Back | 1 | 2 | 3 | 4 | 5 | 6 | Next 20